Key Events This Week
Jan 27: Stock surges 4.70% on strong volume
Jan 28: Intraday high of Rs.1,868 with 7.84% gain; stellar Q3 FY26 results announced
Jan 29: New 52-week and all-time high at Rs.1,947.55; financial trend upgraded
Jan 30: Minor correction of -1.35% closes the week at Rs.1,909.80

Acutaas Chemicals Ltd is Rated Strong Buy
2026-01-31 10:10:05Acutaas Chemicals Ltd is rated 'Strong Buy' by MarketsMOJO, with this rating last updated on 28 January 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 31 January 2026, providing investors with the most up-to-date insight into the stock’s performance and fundamentals.
Read full news article
Acutaas Chemicals Ltd Hits New 52-Week High at Rs.1947.55
2026-01-29 10:08:20Acutaas Chemicals Ltd reached a significant milestone today by hitting a new 52-week high of Rs.1947.55, marking a strong rally in the Pharmaceuticals & Biotechnology sector amid mixed market conditions.
Read full news article
Acutaas Chemicals Ltd Stock Hits All-Time High at Rs 1,947.55
2026-01-29 09:35:34Acutaas Chemicals Ltd has reached a significant milestone by hitting an all-time high of Rs.1947.55 on 29 Jan 2026, reflecting its robust performance in the Pharmaceuticals & Biotechnology sector. The stock’s sustained upward momentum underscores the company’s strong fundamentals and market leadership.
Read full news article
Acutaas Chemicals Ltd Sees Strong Technical Momentum Shift Amid Robust Price Gains
2026-01-29 08:03:15Acutaas Chemicals Ltd has demonstrated a significant shift in price momentum, supported by a range of technical indicators signalling a bullish trend. The stock’s recent surge, coupled with an upgrade in its Mojo Grade to Strong Buy, highlights growing investor confidence in this Pharmaceuticals & Biotechnology sector player.
Read full news article
Acutaas Chemicals Ltd Reports Outstanding Quarterly Performance, Upgrades Financial Trend
2026-01-29 08:00:25Acutaas Chemicals Ltd has delivered an exceptional quarterly performance for December 2025, marking a significant upgrade in its financial trend from very positive to outstanding. The company’s latest results showcase record-breaking revenue, margin expansion, and operational efficiency, prompting MarketsMOJO to upgrade its mojo grade to Strong Buy with a score of 82.0.
Read full news articleAre Acutaas Chemicals Ltd latest results good or bad?
2026-01-28 19:19:05Acutaas Chemicals Ltd has reported its financial results for the quarter ended December 2025, showcasing a strong performance characterized by significant growth in both revenue and net profit. The company's net sales reached ₹393.18 crores, reflecting a year-on-year growth of 42.98% and a sequential increase of 28.41%. This growth notably outpaces the average growth of the pharmaceutical sector, which stands at 11.13%, indicating Acutaas Chemicals' competitive positioning within the industry. The net profit for the same quarter was ₹107.96 crores, marking a substantial year-on-year increase of 140.18% and a sequential growth of 49.45%. This impressive profit growth is complemented by an operating margin of 38.32%, which is a record high for the company, highlighting effective cost management and operational efficiency. The company's return on capital employed (ROCE) for the first half of FY26 reached an ...
Read full news article
Acutaas Chemicals Q3 FY26: Stellar Quarter Drives Stock to New Highs Amid Valuation Concerns
2026-01-28 17:47:08Acutaas Chemicals Ltd., a small-cap pharmaceutical and biotechnology company, delivered an exceptional third quarter performance for FY2026, with consolidated net profit surging 140.18% year-on-year to ₹107.96 crores. The stellar results propelled the stock up 7.84% in Tuesday's trading session to ₹1,864.45, bringing the company's market capitalisation to ₹14,447 crores. With revenues climbing 42.98% YoY to ₹393.18 crores and operating margins expanding to a record 38.32%, the quarter marks a continuation of the company's impressive growth trajectory that has seen its stock soar 98.41% over the past year.
Read full news article






